Mitochondrial haplogroup G is associated with nonalcoholic fatty liver disease, while haplogroup A mitigates the effects of PNPLA3

Abstract Objectives Mitochondrial dysfunction plays a pivotal role in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). We hypothesized that mitochondrial DNA (mtDNA) haplogroups affect the risk of NAFLD in Han Chinese patients and interact with PNPLA3 genotypes. Design NAFLD and control...

Full description

Bibliographic Details
Main Authors: Aaron M. Gusdon, You Hui, Jing Chen, Clayton E. Mathews, Shen Qu
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Endocrinology, Diabetes & Metabolism
Subjects:
Online Access:https://doi.org/10.1002/edm2.187
id doaj-6c373c92caf84d1e9b9fa4bdcd74322a
record_format Article
spelling doaj-6c373c92caf84d1e9b9fa4bdcd74322a2021-02-23T04:16:24ZengWileyEndocrinology, Diabetes & Metabolism2398-92382021-01-0141n/an/a10.1002/edm2.187Mitochondrial haplogroup G is associated with nonalcoholic fatty liver disease, while haplogroup A mitigates the effects of PNPLA3Aaron M. Gusdon0You Hui1Jing Chen2Clayton E. Mathews3Shen Qu4Department of Neurosurgery Mischer Neuroscience Associates University of Texas Health Science Center at Houston Houston TX USADepartment of Endocrinology Shanghai Tenth People's Hospital Tongji University Shanghai ChinaDepartment of Pathology, Immunology and Laboratory Medicine University of Florida College of Medicine Gainesville FL USADepartment of Pathology, Immunology and Laboratory Medicine University of Florida College of Medicine Gainesville FL USADepartment of Endocrinology Shanghai Tenth People's Hospital Tongji University Shanghai ChinaAbstract Objectives Mitochondrial dysfunction plays a pivotal role in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). We hypothesized that mitochondrial DNA (mtDNA) haplogroups affect the risk of NAFLD in Han Chinese patients and interact with PNPLA3 genotypes. Design NAFLD and control patients were recruited from a tertiary care centre. The mitochondrial genome was amplified in overlapping segments and sequenced. Mitochondrial haplogroups were determined using Mitomaster. PNPLA3 rs738409 genotyping was performed using restriction fragment length polymorphism analysis. Patients We enrolled 655 NAFLD patients and 504 controls. Results More NAFLD patients encoded haplogroup G; odds ratio (OR) 1.85 (95% confidence interval [CI] 1.16, 2.80). Subhaplogroup G3 was present more frequently in NAFLD patients (25.8% vs 6.5%). The PNPLA3 CG genotype resulted in an OR of 1.66 (95% CI 1.25, 2.21), and the GG genotype resulted in an OR of 2.33 (95% CI 1.72, 3.17) for NAFLD. Patients with mitochondrial haplogroup A had a significantly higher frequency of genotype GG. Among patients with haplogroup A, no PNPLA3 genotype was associated with increased NAFLD risk (CG: OR 1.17, 95% CI 0.55, 2.34; GG: OR 1.04 95% CI 0.66, 2.65). Excluding haplogroup A, the OR for CG was 1.58 (95% CI 1.18, 2.12), and the OR for GG was 1.81 (95% CI 1.30, 2.51). Conclusion Haplogroup G was associated with an increased risk of NAFLD PNPLA3 GG genotype was overrepresented among patients encoding haplogroup A and was not associated with NAFLD risk among haplogroup A patients. Mitochondrial genetics influence NAFLD risk and interact with PNPLA3 genotypes.https://doi.org/10.1002/edm2.187haplogroupsmitochondriaNAFLDPNPLA3
collection DOAJ
language English
format Article
sources DOAJ
author Aaron M. Gusdon
You Hui
Jing Chen
Clayton E. Mathews
Shen Qu
spellingShingle Aaron M. Gusdon
You Hui
Jing Chen
Clayton E. Mathews
Shen Qu
Mitochondrial haplogroup G is associated with nonalcoholic fatty liver disease, while haplogroup A mitigates the effects of PNPLA3
Endocrinology, Diabetes & Metabolism
haplogroups
mitochondria
NAFLD
PNPLA3
author_facet Aaron M. Gusdon
You Hui
Jing Chen
Clayton E. Mathews
Shen Qu
author_sort Aaron M. Gusdon
title Mitochondrial haplogroup G is associated with nonalcoholic fatty liver disease, while haplogroup A mitigates the effects of PNPLA3
title_short Mitochondrial haplogroup G is associated with nonalcoholic fatty liver disease, while haplogroup A mitigates the effects of PNPLA3
title_full Mitochondrial haplogroup G is associated with nonalcoholic fatty liver disease, while haplogroup A mitigates the effects of PNPLA3
title_fullStr Mitochondrial haplogroup G is associated with nonalcoholic fatty liver disease, while haplogroup A mitigates the effects of PNPLA3
title_full_unstemmed Mitochondrial haplogroup G is associated with nonalcoholic fatty liver disease, while haplogroup A mitigates the effects of PNPLA3
title_sort mitochondrial haplogroup g is associated with nonalcoholic fatty liver disease, while haplogroup a mitigates the effects of pnpla3
publisher Wiley
series Endocrinology, Diabetes & Metabolism
issn 2398-9238
publishDate 2021-01-01
description Abstract Objectives Mitochondrial dysfunction plays a pivotal role in the pathogenesis of nonalcoholic fatty liver disease (NAFLD). We hypothesized that mitochondrial DNA (mtDNA) haplogroups affect the risk of NAFLD in Han Chinese patients and interact with PNPLA3 genotypes. Design NAFLD and control patients were recruited from a tertiary care centre. The mitochondrial genome was amplified in overlapping segments and sequenced. Mitochondrial haplogroups were determined using Mitomaster. PNPLA3 rs738409 genotyping was performed using restriction fragment length polymorphism analysis. Patients We enrolled 655 NAFLD patients and 504 controls. Results More NAFLD patients encoded haplogroup G; odds ratio (OR) 1.85 (95% confidence interval [CI] 1.16, 2.80). Subhaplogroup G3 was present more frequently in NAFLD patients (25.8% vs 6.5%). The PNPLA3 CG genotype resulted in an OR of 1.66 (95% CI 1.25, 2.21), and the GG genotype resulted in an OR of 2.33 (95% CI 1.72, 3.17) for NAFLD. Patients with mitochondrial haplogroup A had a significantly higher frequency of genotype GG. Among patients with haplogroup A, no PNPLA3 genotype was associated with increased NAFLD risk (CG: OR 1.17, 95% CI 0.55, 2.34; GG: OR 1.04 95% CI 0.66, 2.65). Excluding haplogroup A, the OR for CG was 1.58 (95% CI 1.18, 2.12), and the OR for GG was 1.81 (95% CI 1.30, 2.51). Conclusion Haplogroup G was associated with an increased risk of NAFLD PNPLA3 GG genotype was overrepresented among patients encoding haplogroup A and was not associated with NAFLD risk among haplogroup A patients. Mitochondrial genetics influence NAFLD risk and interact with PNPLA3 genotypes.
topic haplogroups
mitochondria
NAFLD
PNPLA3
url https://doi.org/10.1002/edm2.187
work_keys_str_mv AT aaronmgusdon mitochondrialhaplogroupgisassociatedwithnonalcoholicfattyliverdiseasewhilehaplogroupamitigatestheeffectsofpnpla3
AT youhui mitochondrialhaplogroupgisassociatedwithnonalcoholicfattyliverdiseasewhilehaplogroupamitigatestheeffectsofpnpla3
AT jingchen mitochondrialhaplogroupgisassociatedwithnonalcoholicfattyliverdiseasewhilehaplogroupamitigatestheeffectsofpnpla3
AT claytonemathews mitochondrialhaplogroupgisassociatedwithnonalcoholicfattyliverdiseasewhilehaplogroupamitigatestheeffectsofpnpla3
AT shenqu mitochondrialhaplogroupgisassociatedwithnonalcoholicfattyliverdiseasewhilehaplogroupamitigatestheeffectsofpnpla3
_version_ 1724255134692671488